- The Unite Group‘s USAF property portfolio is valued at GBP 2.94 billion as of the second quarter of 2025.
- The LSAV investment portfolio holds a value of GBP 2.09 billion.
- The company has reiterated its guidance for adjusted EPRA Earnings Per Share (EPS) for fiscal year 2025 to be between 47.5p and 48.25p.
- Unite Group anticipates rental growth to be in the range of 4-5% for the 2025/26 academic year.
- The target occupancy rate for the 2025/26 academic year remains high, at 97-98%.
- Student numbers are expected to increase, driven by a rising UK 18-year-old population and a positive trend in international student recruitment.
- Analyst recommendations on the stock include 7 ‘buy’ ratings, 3 ‘hold’ ratings, and 1 ‘sell’ rating.
A look at Unite Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, the long-term outlook for Unite Group appears promising. With solid scores in Value, Dividend, Resilience, the company showcases strength in key areas that investors typically look for. This indicates that Unite Group is well-positioned to deliver value to its shareholders and maintain stability in uncertain market conditions.
While the Growth and Momentum scores are slightly lower, Unite Group‘s focus on student accommodation development in the UK, along with its established relationships with academic institutions, provides a stable foundation for future growth potential. The Company’s diverse portfolio, including specialist funds and joint ventures, further enhances its resilience and long-term sustainability in the property investment sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
